The 340B Drug Pricing Program Explored: A 2013 Perspective
Overview:
Under the 340B Drug Pricing Program, drug manufacturers are required to sell outpatient drugs at a reduced cost to federally-eligible health care facilities certified by the U.S. Department of Health and Human Services (HHS).
The Knowledge Group is producing “The 340B Drug Pricing Program Explored: A 2013 Perspective LIVE Webcast,” to walk the audience through the latest updates of the drug pricing program. Our panel of key regulators and thought leaders will explore significant issues in the mix including:
- Fundamentals of 340B Drug Pricing Program
- 340B Policy Compliance and Enforcement
- Audits of Covered Entities
- Contract Pharmacy
- Inventory Management for 340B Program
- Medicaid Billing, Reimbursement, Duplicate Discounts and Shared Savings
- Best Practices in Indigent Care and Vulnerable Patient Populations
- Regulatory updates
Agenda:
SEGMENT 1:
Krista M. Pedley, PharmD, MS, CDR, USPHS, Director, Office of Pharmacy Affairs,
Health Resources and Services Administration
- Overview of HRSA and Intent of the 340B Drug Pricing Program
- Eligible entities and enrollment
- Program Integrity Initiatives – Annual Recertification and Program Audits
- 340B Resources
SEGMENT 2:
Lidia A. Rodriguez Hupp, Senior Vice President/340B Compliance Officer,
Sentry Data Systems, Inc.
- Compliance
- Operationalizing 340B
- Things to think about
SEGMENT 3:
Maureen Testoni , General Counsel,
Safety Net Hospitals for Pharmaceutical Access
- Overview of 340B program – who it applies to, the positives and negatives of participating in the program
- Major compliance issues
- Hot topics for 2013
SEGMENT 4:
Aaron Vandervelde, Principal, Health Analytics,
Berkeley Research Group, LLC
- Growth drivers in the 340B program in 2013 and beyond
- Areas of risk with contract pharmacy arrangements
- Concerns from pharmaceutical manufacturers
Who Should Attend:
- Federal Healthcare Facilities
- Health Care Law Attorneys
- Health Industry Advisors
- Health Policy Directors
- Bio/Pharma and Related Attorneys
- Compliance Officers
- State Health Executives/Professionals
- General Counsel
- Professionals coming from Food and Drug Industries
- Consultants & Clients in the Food and Drug Industries
- And Other Interested Professionals
CDR Krista M. Pedley is the Director of the Office of Pharmacy Affairs (OPA) in the Health Resources and Services …
Lidia A. Rodriguez-Hupp has 10 – 12 years of experience with 340B software and program maintenance. She has been with …
Maureen Testoni is General Counsel of Safety Net Hospitals for Pharmaceutical Access (SNHPA), which represents hospitals and health systems enrolled …
Aaron Vandervelde is a Principal with Berkeley Research Group’s Health Analytics practice in Washington, DC. He has over 10 years …
Course Level:
Intermediate
Advance Preparation:
Print and review course materials
Method of Presentation:
On-demand Webcast (CLE)
Prerequisite:
NONE
Course Code:
124370
Total Credits:
2.0 CLE
Login Instructions:
No Access
You are not logged in. Please Login or register to the event to gain access to the materials and login instructions.
Unlock All The Knowledge and Credit You Need
Leading Provider of Online Continuing Education
It's As Easy as 1, 2, 3
Get Your 1-Year All Access Pass For Only $199
SPEAKERS' FIRMS:
Health Resources and Services Administration
Safety Net Hospitals for Pharmaceutical Access
Berkeley Research Group, LLC
About Health Resources and Services Administration
About Sentry Data Systems, Inc.
Located in Deerfield Beach, FL, Sentry Data Systems, Inc. is a healthcare intelligence company offering technology solutions that address a wide variety of workflow, compliance, technical and financial challenges. Sentry’s products serve hundreds of hospitals and pharmacies across the country and have saved clients millions of dollars on over 40 million patients to date. Sentry processes millions of eligibility, financial, clinical, and pharmacy transactions per day.
340B Program Management & Compliance
Sentry Data Systems provides industry-leading 340B software applications to hundreds of covered entities and contract pharmacies across the county. Sentry was started and is managed by pharmacists who are focused on meeting the specific and complex data needs of hospitals and retail pharmacies participating in the 340B program. Our web-based solutions provide audit preparation tools, detailed reports, and a documented trail of program compliance from the provider to the patient to the pill to the purchase. Sentry is prepared to adapt to changing legislative requirements and help protect covered entities with a focus on compliance, based upon years of experience assisting and facilitating successful 340B program participation.
Website: https://www.sentryds.com/
About Safety Net Hospitals for Pharmaceutical Access
About Berkeley Research Group, LLC
Berkeley Research Group, LLC is a leading global expert services and consulting firm that provides independent expert testimony, litigation and regulatory support, authoritative studies, strategic advice, and document and data analytics to major law firms, Fortune 500 corporations, government agencies, and regulatory bodies around the world. From testifying in high-stakes litigation to consulting on large-scale projects, BRG experts and consultants combine intellectual rigor with practical, real-world experience and an in-depth understanding of industries and markets. Their expertise spans economics and finance, data analytics and statistics, and public policy in many of the major sectors of our economy, including healthcare, finance, banking, information technology, energy, construction, and real estate. Berkeley Research Group is headquartered in Emeryville, California, with 22 offices across the United States, Australia, Canada, and in London, United Kingdom.